Dermatology

Microbiome researcher Sarah Lebeer studies how beneficial bacteria can help treat inflammatory skin conditions such as acne and atopic dermatitis.

An understudied melanoma arises without sun exposure, but researchers are beginning to shed light on this challenging form of skin cancer. 

A dermatologist and a nanomaterials scientist teamed up to develop synthetic particles to accelerate tissue repair in damaged skin.

Munia Ganguli harnessed cryopreservative chemicals to develop a topical cream that could prevent skin injury from the cold.

Microscopy images reveal the structural change that enlarges an ion channel pore, opening new directions in drug discovery and delivery.

A coordinated effort between the stroma, the immune system, and the skin microbiome restores damaged skin.

Senescent cells in hairy moles release a protein that may lead to innovative hair loss and other regenerative therapies.

A search for a new cancer mouse model turned into the first ever treatment for a rare disease called venous malformations.

Proteins in snake venom could support blood clotting at the site of injury.

Microarray, or microneedle, patches could boost vaccine access in low- and middle-income countries.

There are currently no FDA-approved drugs to treat vitiligo, an autoimmune disease that kills skin pigment cells. But a phase III study of a drug used to treat atopic dermatitis may be the first to get the FDA seal of approval.

From ancient medicines to equipping humans with new senses, tattoos are more than just permanent marks on the skin. They may boost immune function, and they have the potential to effectively deliver therapeutics through the skin.